Published in Nucleic Acids Res on July 25, 1984
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol (1988) 6.44
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol (1989) 4.63
Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol (1990) 3.30
Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J (1985) 3.18
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol (1985) 3.09
Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J (1985) 2.98
Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol (2009) 2.34
Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation. Mol Cell Biol (1987) 1.69
Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells. Mol Cell Biol (1988) 1.62
Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol Cell Biol (1990) 1.58
Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells. Mol Cell Biol (1988) 1.48
Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1990) 1.39
Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J Virol (1987) 1.32
A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization. J Virol (1989) 1.23
Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br J Cancer (1990) 1.21
Intermolecular mRNA-rRNA hybridization and the distribution of potential interaction regions in murine 18S rRNA. Nucleic Acids Res (1993) 1.12
Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J Virol (1988) 1.10
Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res (1988) 1.09
Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts. J Virol (1995) 1.05
Evolutionary conservation of the insulinoma gene rig and its possible function. Proc Natl Acad Sci U S A (1987) 1.02
Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53. J Virol (1989) 0.90
Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors. Yale J Biol Med (1990) 0.86
Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein. Nucleic Acids Res (1988) 0.85
Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration. J Virol (1999) 0.84
p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias. Mol Cell Biol (2001) 0.84
Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression. J Virol (1994) 0.82
Involvement of transcription factor encoded by the mouse mi locus (MITF) in apoptosis of cultured mast cells induced by removal of interleukin-3. Am J Pathol (1997) 0.80
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene (1982) 59.01
An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem (1976) 46.42
Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods Enzymol (1980) 24.43
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A (1980) 22.30
T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78
Plasmid screening at high colony density. Gene (1980) 16.47
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell (1979) 14.05
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27
Synthesis of double-stranded DNA complementary to lysozyme, ovomucoid, and ovalbumin mRNAs. Optimization for full length second strand synthesis by Escherichia coli DNA polymerase I. J Biol Chem (1978) 8.20
Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem (1980) 7.71
Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens. J Virol (1980) 7.51
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell (1980) 6.76
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol (1981) 6.02
Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell (1981) 5.08
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88
Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc Natl Acad Sci U S A (1981) 4.69
Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein. Proc Natl Acad Sci U S A (1981) 3.99
Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A (1982) 3.58
SV40-53K antigen: a possible role for 53K in normal cells. Virology (1981) 3.46
Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. Proc Natl Acad Sci U S A (1982) 3.28
A single gene and a pseudogene for the cellular tumour antigen p53. Nature (1984) 2.98
Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol (1984) 2.88
Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents. J Virol (1981) 2.56
The use of exonuclease III for preparing single stranded DNA for use as a template in the chain terminator sequencing method. Nucleic Acids Res (1979) 2.51
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit. J Virol (1980) 2.07
p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells. Proc Natl Acad Sci U S A (1983) 2.03
Cloning of alpha 2u globulin cDNA using a high efficiency technique for the cloning of trace messenger RNAs. Gene (1981) 1.82
Phosphorylation patterns of tumour antigens in cells lytically infected or transformed by simian virus 40. J Virol (1981) 1.42
Enzymatic synthesis of deoxyribonucleic acid by the avian retrovirus reverse transcriptase in vitro: optimum conditions required for transcription of large ribonucleic acid templates. Biochemistry (1980) 1.10
Evidence that there exist four classes of RNA tumor viruses which encode proteins with associated tyrosine protein kinase activities. J Virol (1981) 1.10
A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species. Proc Natl Acad Sci U S A (1982) 1.02
Lymphocyte stimulation: concanavalin A induces the expression of a 53K protein. Cell Biol Int Rep (1980) 0.96
Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s. Proc Natl Acad Sci U S A (1983) 0.88
Transcription of polyoma DNA by Escherichia coli RNA polymerase: influence of ionic strength on promoter selection. J Virol (1980) 0.80
Ensembl 2006. Nucleic Acids Res (2006) 11.66
Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature (1985) 5.69
Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J (1985) 2.98
Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature (1987) 2.71
Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science (2010) 2.58
A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene (1992) 2.41
Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. Oncogene (1987) 2.32
A controlled trial of disease surveillance strategies. Am J Prev Med (1988) 2.23
The cellular oncogene p53 can be activated by mutagenesis. Nature (1985) 1.99
The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif. Oncogene (1990) 1.75
Paratuberculosis infection of nonruminant wildlife in Scotland. J Clin Microbiol (2001) 1.71
The cost of treating type 2 diabetes (CODEIRE). Ir Med J (2007) 1.67
p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene (1990) 1.59
Mouse mammary tumor virus can mediate cell fusion at reduced pH. Virology (1984) 1.56
Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity. Oncogene (1988) 1.53
HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest (1998) 1.49
Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells. Mol Cell Biol (1988) 1.48
The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res (1992) 1.38
A primigravida allegedly allergic to local anaesthetics. Int J Obstet Anesth (2003) 1.37
Diabetes and alternative medicine: cause for concern. Diabet Med (1994) 1.25
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen. J Virol (1988) 1.24
Improving reading comprehension by using paragraph restatements. Except Child (1987) 1.23
An intravenous 133xenon clearance technique for measuring cerebral blood flow. J Neurol Sci (1979) 1.22
Natural paratuberculosis infection in rabbits in Scotland. J Comp Pathol (2001) 1.18
Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity. Oncogene (1993) 1.17
Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer (2006) 1.16
In vitro synthesis of laminin and entactin polypeptides. J Biol Chem (1983) 1.13
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J (1993) 1.13
Incidence of childhood cancer in Switzerland: the Swiss Childhood Cancer Registry. Pediatr Blood Cancer (2008) 1.12
Sequence divergence of rainbow trout protamine mRNAs; comparison of coding and non-coding nucleotide sequences in three protamine cDNA plasmids. Nature (1979) 1.12
Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene (1995) 1.10
From the other end of the needle. The patient's experience of routine anaesthesia. Anaesthesia (1978) 1.08
A cluster of Legionnaires' disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008-2009. Euro Surveill (2010) 1.07
Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP. Oncogene (1994) 1.06
The relationship between serum p53 autoantibodies and characteristics of human breast cancer. Br J Cancer (1994) 1.04
Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6. Oncogene (1995) 1.02
Effects of tutoring in phonological and early reading skills on students at risk for reading disabilities. J Learn Disabil (2004) 1.01
Experimental paratuberculosis in calves following inoculation with a rabbit isolate of Mycobacterium avium subsp. paratuberculosis. J Clin Microbiol (2001) 0.99
Endogenous HeLa p53 proteins are easily detected in HeLa cells transfected with mouse deletion mutant p53 gene. Oncogene (1991) 0.98
Teaching phonological awareness to young children with learning disabilities. Except Child (1993) 0.96
Human DNA topoisomerases II alpha and II beta can functionally substitute for yeast TOP2 in chromosome segregation and recombination. Mol Gen Genet (1996) 0.95
arg3+, a new selection marker system for Schizosaccharomyces pombe: application of ura4+ as a removable integration marker. Nucleic Acids Res (1995) 0.95
Two approaches to reading instruction with children with disabilities: does program design make a difference? Except Child (1993) 0.95
Cost of anaesthetic drugs and disposable apparatus. Anaesthesia (1978) 0.94
As others see us. The patient's view of the anaesthetist. Anaesthesia (1978) 0.92
Mechanisms of protection induced by live attenuated simian immunodeficiency virus: III. Viral interference and the role of CD8+ T-cells and beta-chemokines in the inhibition of virus infection of PBMCs in vitro. J Med Primatol (2001) 0.91
Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53. J Virol (1989) 0.90
Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. J Appl Physiol (1985) (1990) 0.90
The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry (1989) 0.88
BstNI/NciI polymorphism of the human p53 gene (TP53). Nucleic Acids Res (1991) 0.87
HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS (2000) 0.87
Effects of social integration on preschool children with handicaps. Except Child (1989) 0.85
Transinguinal laparoscopic examination of the contralateral groin in pediatric herniorrhaphy. Surg Laparosc Endosc (1997) 0.84
Insulin treatment, time-zones and air travel: a survey of current advice from British diabetic clinics. Diabet Med (1993) 0.84
Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene. Mol Endocrinol (1988) 0.83
The frequency and impact of restless legs syndrome in primary care. Ir Med J (2007) 0.83
Cost-effective evaluation and management of the acute abdomen. Surg Clin North Am (1996) 0.83
Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins. Oncogene (1996) 0.82
Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells. Exp Cell Res (1999) 0.82
The effect of inhaled 15-(s)-hydroxyeicosatetraenoic acid (15-HETE) on airway calibre and non-specific responsiveness in normal and asthmatic human subjects. Eur Respir J (1990) 0.81
Human cells express two differentially spliced forms of topoisomerase II beta mRNA. Nucleic Acids Res (1993) 0.81
The omnipotent suppressor SUP45 affects nucleic acid metabolism and mitochondrial structure. Yeast (1990) 0.80
Towards automated sleep state estimation using a Holter-oximeter. Conf Proc IEEE Eng Med Biol Soc (2007) 0.80
Clinical use of a portable bedside cerebral blood flow machine in the management of aneurysmal subarachnoid hemorrhage. Neurosurgery (1984) 0.79
Effect of indomethacin on cerebral blood flow, carbon dioxide reactivity and the response to epoprostenol (prostacyclin) infusion in man. J Neurol Neurosurg Psychiatry (1984) 0.78
Myocardial enlargement in defective heart development. Anat Rec (1994) 0.78
Molecular cloning of three major sequence species from Rainbow trout protamine mRNA. Nucleic Acids Res (1979) 0.78
A "no-hybrids" screen for functional antagonizers of human p53 transactivator function: dominant negativity in fission yeast. Oncogene (2001) 0.78
Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo. J Med Primatol (2007) 0.78
Cerebral blood velocity in subarachnoid haemorrhage: a transcranial Doppler study. J Neurol Neurosurg Psychiatry (1987) 0.78
Application of the polymerase chain reaction to the detection of African horse sickness viruses. J Virol Methods (1995) 0.77
Mean hemispheral cerebral blood flow changes after craniotomy. Significance and prognostic value. Acta Neurochir (Wien) (1985) 0.77
The effects of TGF beta on haemopoietic cells. Growth Factors (1989) 0.77
Putative dehydrogenase tms1 suppresses growth arrest induced by a p53 tumour mutant in fission yeast. Eur J Biochem (1993) 0.77
Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M). J Med Primatol (2007) 0.76
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol (2001) 0.76
Defining the minimal requirements for papilloma viral E6-mediated inhibition of human p53 activity in fission yeast. Oncogene (1998) 0.76
Use of a rapid throughput in vivo screen to investigate inhibitors of eukaryotic topoisomerase II enzymes. Antimicrob Agents Chemother (1998) 0.76
Comparison of fast flow and initial slope index values for cerebral blood flow following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1986) 0.75
Comparison of sensory integrative therapy and motor programming. Am J Ment Defic (1983) 0.75
Paradoxical akinetic response to apomorphine in parkinsonism. J Neurol Neurosurg Psychiatry (1992) 0.75
Second-order selection bias. J Occup Med (1994) 0.75
Students' preferences for service delivery: pull-out, in-class, or integrated models. Except Child (1989) 0.75
The effect of novobiocin on yeast topoisomerase type II. Mol Gen Genet (1990) 0.75
Effect of preschool integration for children with disabilities. Except Child (1991) 0.75
Integrating normal and handicapped preschoolers: effects on child development and social interaction. Except Child (1985) 0.75
Coherent combination of high-power, zigzag slab lasers. Opt Lett (2006) 0.75
[Modified oncoprotein p53 in the human tumor cell line HT 1080]. Dokl Akad Nauk SSSR (1987) 0.75
The Lora case: nonbiased referral, assessment, and placement procedures. Except Child (1986) 0.75
Blood flow in the feet of patients recovering from fractures of the tibia and fibula [proceedings]. J Physiol (1977) 0.75
Dissection of the T antigen/mouse p53 complex and its inhibitory effects on viral origin-directed DNA replication in vivo and in vitro. Curr Top Microbiol Immunol (1989) 0.75
[Two immunologically differing forms of p53 oncoprotein from B-lymphocytes of mice are coded with identical mRNA]. Mol Gen Mikrobiol Virusol (1989) 0.75
Categorical programs for remedial and handicapped students: issues of validity. Except Child (1988) 0.75